Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1129-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials ; volume:22 ; number:1 ; day:30 ; month:3 ; year:2021 ; pages:1-11 ; date:12.2021
The journal of headache and pain ; 22, Heft 1 (30.3.2021), 1-11, 12.2021
- Creator
-
Smith, Timothy R.
Spierings, Egilius L. H.
Cady, Roger
Hirman, Joe
Schaeffler, Barbara
Shen, Vivienne
Sperling, Bjørn
Brevig, Thomas
Josiassen, Mette Krog
Brunner, Elizabeth
Honeywell, Loan
Mehta, Lahar
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-021-01227-5
- URN
-
urn:nbn:de:101:1-2021102800440779442230
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Smith, Timothy R.
- Spierings, Egilius L. H.
- Cady, Roger
- Hirman, Joe
- Schaeffler, Barbara
- Shen, Vivienne
- Sperling, Bjørn
- Brevig, Thomas
- Josiassen, Mette Krog
- Brunner, Elizabeth
- Honeywell, Loan
- Mehta, Lahar
- SpringerLink (Online service)
Other Objects (12)
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials
Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials
Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials
Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies